Study reveals CCL2’s role in diabetes-related anxiety disorders
Diabetes mellitus, a significant global health issue, is closely linked to increased rates of anxiety disorders among patients. Epidemiological studies…
Month: май, 2025
Ілінойскі ўніверсітэт запускае анлайн-навучанне па пытаннях псіхічнага здароўя
Гэтай восенню сістэма Універсітэта Ілінойса прадставіць новую анлайн-праграму навучання ў галіне псіхічнага здароўя, прызначаную для выкладчыкаў, супрацоўнікаў,…
Priority Health tackles rising childhood anxiety rates
Priority Health is actively working to combat the rising rates of childhood anxiety, a pressing issue highlighted by recent statistics.…
Employee Anxiety Rises Amid Tariff Uncertainty, Glassdoor Reports
A recent report from Glassdoor reveals a significant decline in employee confidence in April, coinciding with rising anxiety linked to…
Australian study shows nitrous oxide effectively treats depression
A recent study conducted in Australia has demonstrated that nitrous oxide, commonly known as laughing gas, can effectively treat severe…
Study links neighborhood stress to childhood depression risk
Research from Binghamton University indicates that children living in disadvantaged neighborhoods may face a higher risk of developing depression due…
Netball Festival Combats Teen Depression and Cyberbullying
As youth depression and anxiety rates rise, the International Netball Festival offers a platform for young people to connect and…
Wisconsin reports rise in depression and anxiety among teen boys
Wisconsin mental health officials report a concerning trend among teen boys, with rising levels of anxiety, depression, and suicidal thoughts.…
Даследаванне NIMHANS выявіла маркеры ДНК, якія прадказваюць послеродавую дэпрэсію
Нядаўняе даследаванне, праведзенае Нацыянальным інстытутам псіхічнага здароўя і неўралогіі (NIMHANS), выявіла спецыфічныя маркеры ДНК, якія…
Fremanezumab reduces migraine and depression symptoms in trial
A recent clinical trial, known as the phase IV UNITE trial, demonstrated that fremanezumab (Ajovy) effectively reduced both migraine attacks…
Belarusian 
English 
French 
German 
Russian 
Spanish 
Ukrainian